article thumbnail

How the New USPTO Pre-Application Assessment Program Only Reinforces the Need for Integrated & Intelligent Patent Evaluation Software

IP.com

Over the last decade, the total annual patent applications submitted to the United States Patent and Trademark Office (USPTO) each year is over 600,000 applications. The fastest patent review process time is 6-12 months if fast-tracked via Track One , with the average taking up to 22 months.

article thumbnail

VEGAN IP II: Protection of innovation in sustainable materials via patents

Garrigues Blog

How can you use patents to protect the innovation that lies behind plant materials and at the same time secure a competitive edge in the market? Inventive step: The solution proposed by the invention should not be evident from a combination of publications existing at the time the patent application was filed.

IP 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IP Report 2021

LexBlog IP

Interestingly, despite innovation generally being on the rise, 2020 saw a very slight decrease (-2%) in the number of patents filed in Australia. Of the 29,293 patent applications filed, the vast majority were filed by non-residents. Standard Patent Applications and Grants. Innovation Patents. Key Takeaways.

article thumbnail

Patentee doublethink in regulatory submissions and patent prosecution is inequitable conduct: Belcher v. Hospira (US)

The IPKat

Legal Background: Duty of disclosure and inequitable conduct Patent applicants and attorneys prosecuting patent applications at the USPTO have a duty to disclose information that is material to the patentability of the intention ( 37 C.F.R. As such, the patent application indicated, a formulation of pH of 2.8-3.3

article thumbnail

REGENXBIO v. SAREPTA: Make Sure You’re Safely Within the Safe Harbor Before Using a “Research Tool”

Fish & Richardson Trademark & Copyright Thoughts

2008), the Hatch-Waxman Act was intended to eliminate “two unintended distortions of the effective patent term resulting from the premarket approval required for certain products by the [Food, Drug, and Cosmetic Act].” The second distortion was a “de facto extension of effective patent life at the end of the patent term.”

article thumbnail

Keeping up with Belgian patent litigation: Year case law review 2022

The IPKat

At that time, the Opposition Division (OD) of the EPO, as well as the UK and Dutch Courts had already revoked the patent. Novartis kept Mylan out of the Belgian market for a year before the Technical Board of Appeal (TBA) definitively revoked its patent in September 2011.

article thumbnail

Journey Through “Decembers” on SpicyIP (2005 – Present)

SpicyIP

But if your interest is in the specific case studies, Arogyapacha is worth reading, as it exemplifies bringing valuable TK to the market and sharing revenues with an indigenous community. Check Sadhvi Sood’s post discussing Nestle’s patent application for Fennel Flower (Kala Jeera) vis-a-vis TK. Enough Policy stuff now!

IP 64